for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai Pharmaceuticals Holding Co Ltd

601607.SS

Latest Trade

19.06CNY

Change

0.55(+2.97%)

Volume

23,181,856

Today's Range

18.62

 - 

19.16

52 Week Range

15.99

 - 

23.66

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Guotai Junan Securities Says Units Entered Partnership Deal

Jan 8 (Reuters) - Guotai Junan Securities Co Ltd <601211.SS>::UNITS ENTERED PARTNERSHIP DEAL WITH INTERNATIONAL GROUP, SHANGHAI TRUST, JUNJINGHONGFU & OTHER INDEPENDENT THIRD PARTIES.INDEPENDENT THIRD PARTIES UNDER DEAL INCLUDE SHANGHAI PHARMACEUTICALS, SHANGHAI SHANGTOU, SUNING.COM, AMONG OTHERS.

Shanghai Pharmaceuticals' 9-Month Net Profit Up 0.8% Y/Y

Oct 30 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd 2607.HK<601607.SS>::SAYS 9-MONTH NET PROFIT UP 0.8% Y/Y.

Shanghai Pharmaceuticals Holding Received Reply From CSRC

Sept 20 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::RECEIVED REPLY ON APPROVING CO TO ISSUE OVERSEAS LISTED FOREIGN SHARES FROM CSRC.

Shanghai Pharma's Unit To Set Up JV With BIOCAD Holding Hong Kong

Sept 18 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>2607.HK::SAYS UNIT SPH PROJECT BIOCAD LTD AGREES TO SET UP JV SPH-BIOCAD (HK) WITH BIOCAD HOLDING HONG KONG.SAYS UNIT TO INVEST $200.4 MILLION IN THE JV FOR 50.1% STAKE.

Shanghai Pharmaceuticals' H1 Net Profit Up 12.6% Y/Y

Aug 29 (Reuters) - Shanghai Pharmaceuticals Holdings Co Ltd<601607.SS>2607.HK: :SAYS H1 NET PROFIT UP 12.6% Y/Y.

Shanghai Pharmaceuticals Elects Cho Man As Executive Director Of Seventh Session Of Board

June 27 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::CHO MAN, LI YONGZHONG AND SHEN BO WERE ELECTED AS EXECUTIVE DIRECTORS OF SEVENTH SESSION OF BOARD.ZHANG YAOHUA HAVE BEEN APPOINTED AS VICE PRESIDENTS OF CO.

Shanghai Pharmaceuticals Says Board Elects Zhou Jun As Chairman

June 27 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::SAYS BOARD ELECTS ZHOU JUN AS CHAIRMAN.

Shanghai Pharmaceuticals Holding Co Posts Q1 Net Profit Attributable Rmb 1.13 Billion

April 26 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>::Q1 OPERATING REVENUE RMB 46.01 BILLION VERSUS RMB36.39 BILLION.Q1 NET PROFIT ATTRIBUTABLE RMB1.13 BILLION VERSUS RMB1.02 BILLION.

BRIEF-Shanghai Pharmaceuticals Says 2018 Net Profit Up 10.2 Pct, To Issue Debt Financing Instruments

Refiles with additional bullet point and link:SAYS 2018 NET PROFIT UP 10.2 PERCENT Y/Y.SAYS IT PLANS TO ISSUE DEBT FINANCING INSTRUMENTS WORTH UP TO 10.0 BILLION YUAN ($1.49 billion).

Shanghai Pharmaceuticals Sets Aside Goodwill Provisions For 632.4 Million Yuan

March 14 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>2607.HK::SAYS IT SETS ASIDE GOODWILL PROVISIONS FOR 632.4 MILLION YUAN ($94.14 million).

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up